VRTX

Vertex Pharmaceuticals Incorporated

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$438.71

Market Cap

$111.43B

Beta

0.37

P/E

28.2

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+9.27%

EPS Growth (YoY)+500.00%

Revenue CAGR 3Y+10.47%

P/E Ratio28.2

PEG Ratio0.06

FCF Yield+2.87%

Debt / Equity0.21

Interest Coverage320.9x

No credit card required

Already have an account? Sign in to view the full analysis for VRTX.